콘텐츠 바로기

유도솔 프로필
방사선종양학과
유도솔 과장
진료분야
두경부암, 폐암, 식도암, 부인암, 피부암
진료일정
4월
  • 진료
  • 휴진
진료일정 : 일정표

진료과 사정에 따라 인터넷 예약이 불가한 의사도 있습니다.

진료예약

학력/경력

학력

  • 서울대학교 의과대학 방사선종양학과 박사 수료
  • 서울대학교 의과대학 임상의과학과 석사
  • 고려대학교 의학 학사

경력

  • 2019 - 현재 동남권원자력의학원 방사선종양학과 과장
  • 2025 - 현재 동남권원자력의학원 전략연구개발부 부장
  • 2022 - 2025 동남권원자력의학원 국제진료센터 센터장
  • 2017 - 2019 강릉시 강동면보건지소장
  • 2016 - 2017 인천시 옹진군 대청면보건지소 공중보건의
  • 2015 - 2015 미국 Memorial Sloan Kattering 암센터 단기연수
  • 2012 - 2016 서울대학교병원 방사선종양학과 전공의
  • 2011 - 2012 서울대학교병원 수련의

주요활동

  • 호주암학회 정회원
  • 용산구서핑협회 이사
  • 대한폐암학회 법제윤리위원
  • 대한방사선종양학회 고시위원
  • 대한폐암학회 정회원
  • 대한방사선종양학회 정회원
  • 국제방사선연구회 정회원

수상이력

  • 2019 동남권원자력의학원 최우수논문상
  • 2018 강릉 금진 WSB FARM 롱보드 챔피언십 남자 오픈 1위
  • 2015 대한방사선종양학회 정기학술대회 최우수 포스터상 수상
  • 2014 서울대학교병원 국제학술지 전공의 표창수상
  • 2011 제 10회 전국의사 의대생 검도대회 남자 개인전 1위
  • 2010 제 37회 추계 서울시 대학검도연맹전 남자 단체전 1위

연구업적

  • A Phase I/II Trial to Evaluate the Safety and Efficacy of Continuous Positive Airway Pressure in Volumetric Modulated Arc Therapy for Breast Cancer. Park JB & Yu T, et al. Cancer Res Treat 2026 [제1저자]
  • Effects of Ultra-High Dose-Rate Radiotherapy (FLASH-RT) on the Hematopoietic and Immune Systems: An Animal Study. Yu T, et al. Radiation Research 2025 Nov; [제1저자]
  • Resolution-dependent MRI-to-CT translation for orthotopic breast cancer models using deep learning. Ambaye DT, et al. Phy Med Biol 2024 Nov
  • Anti-inflammatory effects of low-dose rate ionizing radiation on cell lines derived from osteoarthritis patients. Song SH, et al. Int J Radiat Res 2024 Jul; [교신저자]
  • Long-term outcome of a multicenter prospective study on efficacy and safety of high-dose Stereotactic Body Radiation Therapy ≥ 48 hour-interfraction interval for ≤ 5 cm hepatocellular carcinoma. Kang J, Kim MS, Jang WI, Han CJ, Kim J, Park SC, Shin YJ, Choi CW, Jeon W, YuT, Chang AR, Park HJ, Park Y, Kim ES, Jo S, Kim WC, Kim HJ, Bae SH, Kim EJ. Liver Cancer 2024 Doi: 10.1159/000541685
  • Optimizing target and diaphragmatic configuration, and dosimetric benefits using continuous positive airway pressure in stereotactic ablative radiotherapy for lung tumors. Park JB, Lee JH, Chang JH, Son J, Kwon S, Choi SY, Shin HW, YuT, Kim HJ. Radiat Oncol J 2024;42(3) [교신저자]
  • Quantitative and qualitative mutational impact of ionizing radiation on normal cells. Youk J, et al. Cell Genomics 2024;4(2):100499
  • 강내 방사선치료에 있어 직장선량 감소를 위한 풍선형 카테터의 검증. Yu T, et al. Journal of the Korean Society of Radiology 2022(16)6:735-740 doi: 10.7742/jksr.2022.16.6.735[제1저자]
  • Correlation Between Average Segment Width and Gamma Passing Rate as a Function of MLC Position Error in Volumetric Modulated Arc Therapy. Moon YM, Bae SI, Han MJ, Jeon W, YuT, Choi CW, Kim JY. Tech Cancer Res Treat 2021 Nov. DOI: 10.1177/15330338211059937
  • Treatment outcomes of stereotactic ablative radiation therapy for non-spinal bone metastases: focus on response assessment and treatment indication. YuT, Choi C-W, Kim KS. The British Journal of Radiology 2019 Jul;92(1099):20181048. [제1저자]
  • Stereotactic body radiotherapy for centrally located primary non-small cell lung cancer: a meta-analysis. YuT, Shin IS, Yoon WS, Rim CH. Clin Lung Cancer. 2019 Jul;20(4):e452-e462. [제1저자]
  • Early closure of a Phase I clinical trial of SABR in early-stage glottis cancer. Kang BH, YuT, Kim J, Park JM, Kim JI, Chung EJ, Kwon SK, Kim JH, Wu HG. Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):104-109.
  • Study design and early result of a phase I study of SABR for early-stage glottic cancer. YuT, Wee CW, Choi N, Wu HG, Kang HC, Park JM, Kim JI, Kim JH, Kwon TK, Chung EJ. Laryngoscope. 2018 Nov 128(11):2560-2565. [제1저자]
  • Which Is Better for Liver SBRT: Dosimetric Comparison Between DCAT and VMAT for Liver Tumors. Moon YM, Jean W, YuT, Bae SI, Kim JY, Kang JK, Choi CW. Front Oncol. 2020 Jul 29;10:1170
  • Evaluation of the Attenuation Rate for Clinical Application of a Flexible Skin Dosimeter in Radiotherapy. Han MJ, Yang SW, Shin YH, Bae SI, Moon YM, Jeon W, YuT, Kang JK, Kim JY, Heo SU, Park SK, Rah JE, Chung JB. J Korean Phys Soc. 2020 Nov 77:1144-1048
  • Does fluid collection impact radiotherapy outcomes after wide excision of lower extremity soft tissue sarcoma? Choi N, Kim JY, YuT, Kang HC, Kim HS, Kim HJ, Kim I. Jpn J Clin Oncol. 2017 Nov 48(2):1-7.
  • Effects of an Oral Health Promotion Program in Head and Neck Cancer Patients Receiving Radiation Therapy: Results of a Prospective Cohort Study. Kim E, Wu HG, Kim JH, Kim KS, YuT, Wee CW, Choi N, Jang BS, Jeon SH, Lee HJ, Han DH. Int J Radiat Oncol Biol Phys. 2017 Oct 99(2):E348
  • Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells. YuT, Cho BJ, Choi EJ, Park JM, Kim DH, Kim IA. Oncotarget. 2016 Oct 12:7(48):79089-79100. [제1저자]
  • Objective Measurement of Cosmetic Outcomes of Breast Conserving Therapy Using BCCT.core. YuT, Eom KY, Jang NY, Kim KS, Koo TR, Kwon J, Kim BH, Kang E, Kim SW, Kim JS, Kim IA. Cancer Res Treat. 2016 Apr 22;48(2):491-8. [제1저자]
  • Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean radiation oncology group study 13-12. YuT, Kang HC, Lim do H, Kim IH, Chung WK, Suh CO, Choi BO, Cho KH, Cho JH, Kim JH, Park CK, Hong YK, Kim IA. J Neurooncol. 2015 Feb;121(3):531-9. [제1저자]
  • A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12. Kang HC, YuT, Lim DH, Kim IH, Chung WK, Suh CO, Choi BO, Cho WH, Cho JH, Kim JH, Nam DH, Park CK, Hong YK, Kim IA. J Neurooncol. 2015 Oct:125(1):207-15.
  • Radiosensitizing effect of Lapatinib in HER2-positive breast cancer cells (Master’s thesis). YuT. (2015). Available from http://library.snu.ac.kr/[제1저자]
  • Outcome analysis in patients with uterine sarcoma. YuT, Kim HJ, Wu HG, Ha SW, Song YS, Park NH, Kim JW. Radiat Oncol J. 2015 Mar;33(1). [제1저자]
  • Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer. Kim MY, YuT, Wu HG. Jpn J Clin Oncol. 2014 Apr;44(4):331-7. (SCIE)
  • Fluorodeoxyglucose positron-emission tomography ratio in non-small cell lung cancer patients treated with definitive radiotherapy. Kang HC, Wu HG, YuT, Kim HJ, Paeng JC. Radiat Oncol J. 2013 Sep;31(3):111-7. (ESCI)